Clinical Trial Update: Diazoxide In the Management Of Hypoglycemic Neonates [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on diazoxide for managing hypoglycemia in newborns, spanning Phase 2 and Phase 3; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia
• Neonatal Hypoglycemia

Drugs mentioned

• DIAZOXIDE (DIAZOXIDE)

Snippet

Sponsor: University of Saskatchewan | Conditions: Infant, Newborn, Diseases, Pregnancy in Diabetics | Phase 2, Phase 3 | Status: UNKNOWN